By Matthew Carr One of the major drags on U.S. pot stocks has been the lack of merger and acquisition (M&A) approvals.
This weighed on shares in 2019.
Over the past couple of years, cannabis companies raced to corner the market and secure growth at all costs.
We cheered as deal after deal after deal was announced. The money seemed to flow like water as record price tags were paid.
But the party came to a glass-shattering stop. And the proposed deals got sucked into the black hole of the Hart-Scott-Rodino (HSR) Antitrust Improvements Act.
As the HSR delays dragged out, pot stocks tanked and M&A deals started …read more
